Pfizer – Antibiotic Stewardship in Pediatrics – Request for Proposals

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire within your unit

Memorial Deadline: Monday 5th, July 2021

External Deadline: Thursday 8th, July 2021


Description

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Areas of Interest.

The purpose of this RFP is to support antibiotic stewardships in pediatrics. In resource limited settings, antibiotic use in children is common with evidence suggesting both overuse in many settings and underuse in others. Further, differences in usage based on gender and/or class suggest inequities that need to be addressed. Interventions are needed to ensure good stewardship practices are applied to children, one of the most vulnerable populations.

Important Dates

  • * RFP release date: May 28,
  • * 2021•Grant Application due date: July 8, 2021
  • • Anticipated Grant Award Notification Date: August 2021
  • • Grants will be distributed following a fully executed agreement.
  • • Anticipated Project Start and End Dates: Projects can only begin upon contract execution, which is anticipated to occur by October 1, 2021.

Please note the deadline is 23:59 Eastern Standard Time (e.g. New York, GMT -5). July 8, 2021

Additional information can be found here.


Funding Sources

Pfizer Inc



This opportunity was posted by: RGCS

Last modified: May 28, 2021